Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,880 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia.
Shima H, Kada A, Tanizawa A, Sato I, Tono C, Ito M, Yuza Y, Watanabe A, Kamibeppu K, Uryu H, Koh K, Imai C, Yoshida N, Koga Y, Fujita N, Saito AM, Adachi S, Ishii E, Shimada H. Shima H, et al. Among authors: koga y. Pediatr Blood Cancer. 2022 Aug;69(8):e29699. doi: 10.1002/pbc.29699. Epub 2022 Apr 11. Pediatr Blood Cancer. 2022. PMID: 35403816
Haematopoietic stem cell transplantation for relapsed or refractory anaplastic large cell lymphoma: a study of children and adolescents in Japan.
Fukano R, Mori T, Kobayashi R, Mitsui T, Fujita N, Iwasaki F, Suzumiya J, Chin M, Goto H, Takahashi Y, Hara J, Park YD, Inoue M, Koga Y, Inagaki J, Sakamaki H, Adachi S, Kawa K, Kato K, Suzuki R. Fukano R, et al. Among authors: koga y. Br J Haematol. 2015 Feb;168(4):557-63. doi: 10.1111/bjh.13167. Epub 2014 Oct 14. Br J Haematol. 2015. PMID: 25312752 Free article.
Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A, Shioda Y, Imamura T, Kudo K, Kawaguchi H, Sakashita K, Yasui M, Koga Y, Kobayashi R, Ishii E, Fujimoto J, Horibe K, Bessho F, Tsunematsu Y, Imashuku S. Morimoto A, et al. Among authors: koga y. Int J Hematol. 2016 Jul;104(1):99-109. doi: 10.1007/s12185-016-1993-3. Epub 2016 Apr 4. Int J Hematol. 2016. PMID: 27040279
Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation.
Kobayashi R, Mitsui T, Fujita N, Osumi T, Aoki T, Aoki K, Suzuki R, Fukuda T, Miyamoto T, Kato K, Nakamae H, Goto H, Eto T, Inoue M, Mori T, Terui K, Onizuka M, Koh K, Koga Y, Ichinohe T, Sawada A, Atsuta Y, Suzumiya J. Kobayashi R, et al. Among authors: koga y. Int J Hematol. 2017 Mar;105(3):369-376. doi: 10.1007/s12185-016-2120-1. Epub 2016 Oct 27. Int J Hematol. 2017. PMID: 27787746
Pediatric follicular lymphoma in Japan.
Kobayashi R, Tanaka F, Nakazawa A, Ueyama JI, Sunami S, Mitsui T, Koga Y, Mori T, Osumi T, Fukano R, Ohki K, Sekimizu M, Fujita N, Kamei M, Mori T; Lymphoma Committee and Japanese Pediatric Leukemia/Lymphoma Study Group. Kobayashi R, et al. Among authors: koga y. Int J Hematol. 2017 Jun;105(6):849-853. doi: 10.1007/s12185-017-2209-1. Epub 2017 Mar 7. Int J Hematol. 2017. PMID: 28271414
Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: study protocol.
Sekimizu M, Iguchi A, Mori T, Koga Y, Kada A, Saito AM, Horibe K. Sekimizu M, et al. Among authors: koga y. BMC Cancer. 2018 Feb 1;18(1):122. doi: 10.1186/s12885-018-4042-1. BMC Cancer. 2018. PMID: 29390984 Free PMC article. Clinical Trial.
A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm Open-label Trial.
Sekimizu M, Osumi T, Fukano R, Koga Y, Kada A, Saito AM, Mori T. Sekimizu M, et al. Among authors: koga y. Acta Med Okayama. 2018 Aug;72(4):431-436. doi: 10.18926/AMO/56184. Acta Med Okayama. 2018. PMID: 30140094 Free article.
The Effect of Interim FDG-PET-guided Response-Adapted Therapy in Pediatric Patients with Hodgkin's Lymphoma (HL-14) : Protocol for a Phase II Study.
Koga Y, Baba S, Fukano R, Nakamura K, Soejima T, Maeda N, Sunami S, Ueyama J, Mitsui T, Mori T, Osumi T, Sekimizu M, Ohki K, Tanaka F, Kamei M, Fujita N, Mori T, Saito AM, Kada A, Kobayashi R. Koga Y, et al. Acta Med Okayama. 2018 Aug;72(4):437-440. doi: 10.18926/AMO/56185. Acta Med Okayama. 2018. PMID: 30140095 Free article.
Impact of low-dose irradiation and in vivo T-cell depletion on hematopoietic stem cell transplantation for non-malignant diseases using fludarabine-based reduced-intensity conditioning.
Umeda K, Yabe H, Kato K, Imai K, Kobayashi M, Takahashi Y, Yoshida N, Sato M, Sasahara Y, Kato K, Adachi S, Koga Y, Okada K, Inoue M, Hashii Y, Atsuta Y, Morio T; Inherited Disease Working Group of the Japan Society for Hematopoietic Cell Transplantation. Umeda K, et al. Among authors: koga y. Bone Marrow Transplant. 2019 Aug;54(8):1227-1236. doi: 10.1038/s41409-018-0418-8. Epub 2018 Dec 7. Bone Marrow Transplant. 2019. PMID: 30531957
1,880 results